Commentary: GM1-Gangliosidosis Type III Associated Parkinsonism
Mov Disord Clin Pract
.
2021 Sep 3;8(Suppl 1):S24-S25.
doi: 10.1002/mdc3.13301.
eCollection 2021 Aug.
Authors
Manju A Kurian
1
2
,
Rauan Kaiyrzhanov
3
4
,
Parvin Allahyarova
5
6
,
Ulviyya Guliyeva
7
,
Sughra Gulieva
7
,
Kamran Salayev
5
,
Aytan Mursalova
5
,
Matteo P Ferla
8
9
,
Henry Houlden
3
,
Francisco Cardoso
10
Affiliations
1
Molecular Neurosciences, Developmental Neurosciences UCL Great Ormond Street Institute of Child Health London United Kingdom.
2
Department of Neurology Great Ormond Street Hospital London United Kingdom.
3
Department of Neuromuscular Disorders Institute of Neurology, University College London London United Kingdom.
4
Department of Neurology South Kazakhstan Medical Academy Shymkent Kazakhstan.
5
Department of Neurology Azerbaijan Medical University Baku Azerbaijan.
6
Bona Dea International Hospital Baku Azerbaijan.
7
MediClub Hospital Baku Azerbaijan.
8
NIHR Oxford BRC Genomic Medicine, Wellcome Centre for Human Genetics, University of Oxford Oxford United Kingdom.
9
Structural Genomics Consortium University of Oxford Oxford United Kingdom.
10
Movement Disorders Unit Neurology Service, The Federal University of Minas Gerais Belo Horizonte Brazil.
PMID:
34514041
PMCID:
PMC8414508
DOI:
10.1002/mdc3.13301
No abstract available
Publication types
Editorial